Literature DB >> 1276478

Distribution of phospholipids, fatty acids, and platelet factor 3 activity among subcellular fractions of human platelets.

M J Broekman, R I Handin, A Derksen, P Cohen.   

Abstract

As compared with other methods, our recently reported method for subcellular fractionation of human platelets improves the separation of mitochondria, alpha granules, and lysosomal enzyme activities. The relative purity of these fractions has led us to undertake the present study to compare the subcellular distribution of phospholipids, fatty acids, and platelet factor 3 (clot-promoting) activity. Two findings pertaining to distribution of phospholipids were entirely new. (1) In the alpha granule zone, plasmalogen phosphatidyl ethanolamine peaked at the expense of diacyl phosphatidyl ethanolamine. (2) The fatty acid composition of the membrane lysophosphatidyl choline suggested that it may have been formed by the action of platelet phospholipase A2 activity. The fatty acids of the membranes showed a markedly asymmetrical distribution in noncholine versus choline phospholipids. The latter held 94%, 72%, and 85%, respectively, of the total content of 16:0, 18:1, and 18:2 fatty acids, whereas 55% of the 18:0, 72% of 20:4, and 67% of higher polyenoic acids other than 20:4 were esterified to the noncholine group. The most important new information related to clot-promoting activity, which, on the basis of protein content, was highest in the membrane fractions, but on the basis of phospholipid content in the nonmembranous fractions. The discussion centers on possible explanations for this novel finding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276478

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Are phospholipases involved in platelet activation?

Authors:  G Bereziat
Journal:  Agents Actions       Date:  1979-10

2.  Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.

Authors:  D Hahnel; T Huber; V Kurze; K Beyer; B Engelmann
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.

Authors:  B Engelmann; C Kögl; R Kulschar; B Schaipp
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

4.  Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.

Authors:  M J Broekman; J W Ward; A J Marcus
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

5.  Fatty acid composition of subcellular particles from sheep platelets and topological distribution of phosphatidylethanolamine fatty acids in the plasma membrane.

Authors:  J Sánchez-Yagüe; J A Cabezas; M Llanillo
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

6.  Lupus anticoagulant antibodies inhibit collagen-induced adhesion and aggregation of human platelets in vitro.

Authors:  I Ostfeld; N Dadosh-Goffer; S Borokowski; J Talmon; A Mani; U Zor; J Lahav
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

7.  Arachidonic acid release from diacyl phosphatidylethanolamine by human platelet membranes.

Authors:  R L Jesse; P Cohen
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

8.  Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Authors:  A J Marcus; B B Weksler; E A Jaffe; M J Broekman
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.

Authors:  Ayşe Demirkan; Cornelia M van Duijn; Peter Ugocsai; Aaron Isaacs; Peter P Pramstaller; Gerhard Liebisch; James F Wilson; Åsa Johansson; Igor Rudan; Yurii S Aulchenko; Anatoly V Kirichenko; A Cecile J W Janssens; Ritsert C Jansen; Carsten Gnewuch; Francisco S Domingues; Cristian Pattaro; Sarah H Wild; Inger Jonasson; Ozren Polasek; Irina V Zorkoltseva; Albert Hofman; Lennart C Karssen; Maksim Struchalin; James Floyd; Wilmar Igl; Zrinka Biloglav; Linda Broer; Arne Pfeufer; Irene Pichler; Susan Campbell; Ghazal Zaboli; Ivana Kolcic; Fernando Rivadeneira; Jennifer Huffman; Nicholas D Hastie; Andre Uitterlinden; Lude Franke; Christopher S Franklin; Veronique Vitart; Christopher P Nelson; Michael Preuss; Joshua C Bis; Christopher J O'Donnell; Nora Franceschini; Jacqueline C M Witteman; Tatiana Axenovich; Ben A Oostra; Thomas Meitinger; Andrew A Hicks; Caroline Hayward; Alan F Wright; Ulf Gyllensten; Harry Campbell; Gerd Schmitz
Journal:  PLoS Genet       Date:  2012-02-16       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.